Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells

Margherita Mariani, Rosmarie Lang, Elisa Binda, Paola Panina-Bordignon, Daniele D'Ambrosio

Research output: Contribution to journalArticle

Abstract

Chemokines and their receptors play a pivotal role in controlling T cell trafficking in immunity and inflammation. Two chemokines, CCL17 and CCL22, activate the chemokine receptor CCR4, expressed on functionally distinct subsets of T cells: cutaneous leukocyte-associated antigen (CLA)+ skin-homing, T helper (Th) 2, and CD25+ T suppressor cells. Here, we compared the ability of CCL17 and CCL22 to promote CCR4 internalization as a mechanism of regulation of receptor function on human Th2 cells. We report that CCL22 is a potent and rapid inducer of CCR4 internalization, while CCL17 is not. CCR4 internalization does not require G protein coupling, while being dependent on lipid rafts integrity and clathrin-coated pits functionality. Cell surface disappearance of CCR4 is rapidly reversed upon removal of exogenous ligand by virtue of receptor recycling. CCR4 internalization leads to a loss of functional responsiveness, while recovery of surface expression leads to re-acquisition of chemotactic sensitivity of Th2 cells. The differential CCR4 desensitization and internalization reported here and the distinct expression patterns of CCL17 and CCL22 observed in vivo suggest that while CCL17 may act first on CCR4 at the endothelial surface to promote vascular recognition, CCL22 could subsequently engage the receptor within the tissue microenvironment to guide cellular localization.

Original languageEnglish
Pages (from-to)231-240
Number of pages10
JournalEuropean Journal of Immunology
Volume34
Issue number1
DOIs
Publication statusPublished - Jan 2004

Fingerprint

Th2 Cells
Chemokine Receptors
Chemokine CCL22
Chemokine CCL17
Clathrin
Skin
T-Lymphocyte Subsets
HLA Antigens
GTP-Binding Proteins
Blood Vessels
Immunity
Ligands
Inflammation
T-Lymphocytes
Lipids

Keywords

  • Chemokine receptor
  • Inflammation
  • Leukocyte migration
  • Th2 cells

ASJC Scopus subject areas

  • Immunology

Cite this

Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. / Mariani, Margherita; Lang, Rosmarie; Binda, Elisa; Panina-Bordignon, Paola; D'Ambrosio, Daniele.

In: European Journal of Immunology, Vol. 34, No. 1, 01.2004, p. 231-240.

Research output: Contribution to journalArticle

Mariani, Margherita ; Lang, Rosmarie ; Binda, Elisa ; Panina-Bordignon, Paola ; D'Ambrosio, Daniele. / Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. In: European Journal of Immunology. 2004 ; Vol. 34, No. 1. pp. 231-240.
@article{f105c7d1ed984413b003a175963dc8b5,
title = "Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells",
abstract = "Chemokines and their receptors play a pivotal role in controlling T cell trafficking in immunity and inflammation. Two chemokines, CCL17 and CCL22, activate the chemokine receptor CCR4, expressed on functionally distinct subsets of T cells: cutaneous leukocyte-associated antigen (CLA)+ skin-homing, T helper (Th) 2, and CD25+ T suppressor cells. Here, we compared the ability of CCL17 and CCL22 to promote CCR4 internalization as a mechanism of regulation of receptor function on human Th2 cells. We report that CCL22 is a potent and rapid inducer of CCR4 internalization, while CCL17 is not. CCR4 internalization does not require G protein coupling, while being dependent on lipid rafts integrity and clathrin-coated pits functionality. Cell surface disappearance of CCR4 is rapidly reversed upon removal of exogenous ligand by virtue of receptor recycling. CCR4 internalization leads to a loss of functional responsiveness, while recovery of surface expression leads to re-acquisition of chemotactic sensitivity of Th2 cells. The differential CCR4 desensitization and internalization reported here and the distinct expression patterns of CCL17 and CCL22 observed in vivo suggest that while CCL17 may act first on CCR4 at the endothelial surface to promote vascular recognition, CCL22 could subsequently engage the receptor within the tissue microenvironment to guide cellular localization.",
keywords = "Chemokine receptor, Inflammation, Leukocyte migration, Th2 cells",
author = "Margherita Mariani and Rosmarie Lang and Elisa Binda and Paola Panina-Bordignon and Daniele D'Ambrosio",
year = "2004",
month = "1",
doi = "10.1002/eji.200324429",
language = "English",
volume = "34",
pages = "231--240",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "wiley",
number = "1",

}

TY - JOUR

T1 - Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells

AU - Mariani, Margherita

AU - Lang, Rosmarie

AU - Binda, Elisa

AU - Panina-Bordignon, Paola

AU - D'Ambrosio, Daniele

PY - 2004/1

Y1 - 2004/1

N2 - Chemokines and their receptors play a pivotal role in controlling T cell trafficking in immunity and inflammation. Two chemokines, CCL17 and CCL22, activate the chemokine receptor CCR4, expressed on functionally distinct subsets of T cells: cutaneous leukocyte-associated antigen (CLA)+ skin-homing, T helper (Th) 2, and CD25+ T suppressor cells. Here, we compared the ability of CCL17 and CCL22 to promote CCR4 internalization as a mechanism of regulation of receptor function on human Th2 cells. We report that CCL22 is a potent and rapid inducer of CCR4 internalization, while CCL17 is not. CCR4 internalization does not require G protein coupling, while being dependent on lipid rafts integrity and clathrin-coated pits functionality. Cell surface disappearance of CCR4 is rapidly reversed upon removal of exogenous ligand by virtue of receptor recycling. CCR4 internalization leads to a loss of functional responsiveness, while recovery of surface expression leads to re-acquisition of chemotactic sensitivity of Th2 cells. The differential CCR4 desensitization and internalization reported here and the distinct expression patterns of CCL17 and CCL22 observed in vivo suggest that while CCL17 may act first on CCR4 at the endothelial surface to promote vascular recognition, CCL22 could subsequently engage the receptor within the tissue microenvironment to guide cellular localization.

AB - Chemokines and their receptors play a pivotal role in controlling T cell trafficking in immunity and inflammation. Two chemokines, CCL17 and CCL22, activate the chemokine receptor CCR4, expressed on functionally distinct subsets of T cells: cutaneous leukocyte-associated antigen (CLA)+ skin-homing, T helper (Th) 2, and CD25+ T suppressor cells. Here, we compared the ability of CCL17 and CCL22 to promote CCR4 internalization as a mechanism of regulation of receptor function on human Th2 cells. We report that CCL22 is a potent and rapid inducer of CCR4 internalization, while CCL17 is not. CCR4 internalization does not require G protein coupling, while being dependent on lipid rafts integrity and clathrin-coated pits functionality. Cell surface disappearance of CCR4 is rapidly reversed upon removal of exogenous ligand by virtue of receptor recycling. CCR4 internalization leads to a loss of functional responsiveness, while recovery of surface expression leads to re-acquisition of chemotactic sensitivity of Th2 cells. The differential CCR4 desensitization and internalization reported here and the distinct expression patterns of CCL17 and CCL22 observed in vivo suggest that while CCL17 may act first on CCR4 at the endothelial surface to promote vascular recognition, CCL22 could subsequently engage the receptor within the tissue microenvironment to guide cellular localization.

KW - Chemokine receptor

KW - Inflammation

KW - Leukocyte migration

KW - Th2 cells

UR - http://www.scopus.com/inward/record.url?scp=1642554783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642554783&partnerID=8YFLogxK

U2 - 10.1002/eji.200324429

DO - 10.1002/eji.200324429

M3 - Article

C2 - 14971049

AN - SCOPUS:1642554783

VL - 34

SP - 231

EP - 240

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 1

ER -